← Browse by Condition
Medical Condition

hyperprogression

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06276088
Recruiting

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Enrollment
374 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →